Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Journal
The Lancet Oncology
Journal Volume
17
Journal Issue
6
Pages
717-726
Date Issued
2016
Author(s)
Muro K.
Chung H.C.
Shankaran V.
Geva R.
Catenacci D.
Gupta S.
Eder J.P.
Golan T.
Le D.T.
Burtness B.
McRee A.J.
Pathiraja K.
Lunceford J.
Emancipator K.
Juco J.
Koshiji M.
Bang Y.-J.
SDGs
Publisher
Lancet Publishing Group
Type
journal article